DK0820473T4 - Biologisk nedbrydelige polyacetalpolymerer og dannelse og anvendelse - Google Patents
Biologisk nedbrydelige polyacetalpolymerer og dannelse og anvendelseInfo
- Publication number
- DK0820473T4 DK0820473T4 DK96912522T DK96912522T DK0820473T4 DK 0820473 T4 DK0820473 T4 DK 0820473T4 DK 96912522 T DK96912522 T DK 96912522T DK 96912522 T DK96912522 T DK 96912522T DK 0820473 T4 DK0820473 T4 DK 0820473T4
- Authority
- DK
- Denmark
- Prior art keywords
- biodegradable biocompatible
- polyacetals
- biodegradable
- formation
- administration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L59/00—Compositions of polyacetals; Compositions of derivatives of polyacetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1213—Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G4/00—Condensation polymers of aldehydes or ketones with polyalcohols; Addition polymers of heterocyclic oxygen compounds containing in the ring at least once the grouping —O—C—O—
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/421,766 US5811510A (en) | 1995-04-14 | 1995-04-14 | Biodegradable polyacetal polymers and methods for their formation and use |
PCT/US1996/004476 WO1996032419A1 (fr) | 1995-04-14 | 1996-04-01 | Polymeres de polyacetals biodegradables, formation et utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0820473T3 DK0820473T3 (da) | 2001-10-22 |
DK0820473T4 true DK0820473T4 (da) | 2008-05-13 |
Family
ID=23671966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96912522T DK0820473T4 (da) | 1995-04-14 | 1996-04-01 | Biologisk nedbrydelige polyacetalpolymerer og dannelse og anvendelse |
Country Status (10)
Country | Link |
---|---|
US (3) | US5811510A (fr) |
EP (1) | EP0820473B2 (fr) |
JP (1) | JP4187265B2 (fr) |
AT (1) | ATE202573T1 (fr) |
AU (1) | AU5531296A (fr) |
CA (1) | CA2215997C (fr) |
DE (1) | DE69613569T3 (fr) |
DK (1) | DK0820473T4 (fr) |
GR (1) | GR3036696T3 (fr) |
WO (1) | WO1996032419A1 (fr) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
EP0988550A1 (fr) * | 1997-06-18 | 2000-03-29 | Elvira Schecklies | Formulation pour systemes reactionnels immunologiques |
EP1037642B9 (fr) * | 1997-12-09 | 2010-10-13 | Biomedical Frontiers, Inc. | Polysaccharides a reconnaissance biologique modifiee |
US6958148B1 (en) * | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
EP1206285A2 (fr) * | 1999-08-09 | 2002-05-22 | The General Hospital Corporation | Complexes vecteurs de medicament et technique d'utilisation de ceux-ci |
US8106098B2 (en) * | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
WO2002020663A2 (fr) * | 2000-09-06 | 2002-03-14 | Ap Pharma, Inc. | Polymeres degradables de polyacetal |
US7250048B2 (en) | 2001-04-26 | 2007-07-31 | Medtronic, Inc. | Ablation system and method of use |
US6648883B2 (en) | 2001-04-26 | 2003-11-18 | Medtronic, Inc. | Ablation system and method of use |
DE60323936D1 (de) | 2002-01-14 | 2008-11-20 | Gen Hospital Corp | Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung |
EP1585817B1 (fr) * | 2002-02-20 | 2009-09-02 | The General Hospital Corporation | Conjugues contenant un polymere biodegradable, et leurs utilisations |
JP4925581B2 (ja) * | 2002-07-05 | 2012-04-25 | 旭化成株式会社 | 体液適合性および生体適合性を有する樹脂 |
CA2492803C (fr) * | 2002-07-19 | 2013-11-05 | The General Hospital Corporation | Conjugats d'oximes, procedes de synthese de ces produits et leurs usages |
WO2004009774A2 (fr) * | 2002-07-19 | 2004-01-29 | Amgen Inc. | Conjugues de proteines avec un polymere biodegradable, biocompatible soluble dans l'eau |
US7045589B2 (en) | 2002-11-15 | 2006-05-16 | A.P. Pharma, Inc. | Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
US6878374B2 (en) * | 2003-02-25 | 2005-04-12 | Nitto Denko Corporation | Biodegradable polyacetals |
US7048925B2 (en) | 2003-08-28 | 2006-05-23 | Nitto Denko Corporation | Acid-sensitive polyacetals and methods |
US7790150B2 (en) * | 2003-09-05 | 2010-09-07 | The General Hospital Corporation | Dual phase drug release system |
US20050181018A1 (en) * | 2003-09-19 | 2005-08-18 | Peyman Gholam A. | Ocular drug delivery |
JP4586022B2 (ja) * | 2003-09-29 | 2010-11-24 | 日東電工株式会社 | インビボポリヌクレオチド送達用生分解性ポリアセタール |
DE102004023117A1 (de) * | 2004-05-11 | 2005-12-08 | A. u. K. Müller GmbH & Co KG | Elektromagnetventil für flüssige Medien, insbesondere Heißwasser |
US7358223B2 (en) * | 2004-10-04 | 2008-04-15 | Nitto Denko Corporation | Biodegradable cationic polymers |
WO2006044986A1 (fr) * | 2004-10-18 | 2006-04-27 | Nitto Denko Corporation | Relargage intracellulaire de peptides |
AU2005314426A1 (en) | 2004-12-10 | 2006-06-15 | Talima Therapeutics, Inc. | Compositions and methods for treating conditions of the nail unit |
US20060275230A1 (en) | 2004-12-10 | 2006-12-07 | Frank Kochinke | Compositions and methods for treating conditions of the nail unit |
US7674452B2 (en) * | 2005-03-16 | 2010-03-09 | Nitto Denko Corporation | Polymer coating of cells |
US7341720B2 (en) * | 2005-04-06 | 2008-03-11 | Genzyme Corporation | Targeting of glycoprotein therapeutics |
US20060229585A1 (en) * | 2005-04-11 | 2006-10-12 | Minu, L.L.C. | Drug delivery to the crystalline lens and other ocular structures |
US7722581B2 (en) * | 2005-04-11 | 2010-05-25 | Gholam A. Peyman | Crystalline lens drug delivery |
US7588754B2 (en) * | 2005-05-10 | 2009-09-15 | Nitto Denko Corporation | Biodegradable polyacetals and methods |
US20060263328A1 (en) * | 2005-05-19 | 2006-11-23 | Sang Van | Hydrophilic polymers with pendant functional groups and method thereof |
WO2007098041A1 (fr) * | 2006-02-17 | 2007-08-30 | Medtronic, Inc. | Polymeres de polycetal et leurs procedes de fabrication et d'utilisation |
US7700541B2 (en) * | 2006-04-06 | 2010-04-20 | Nitto Denko Corporation | Biodegradable cationic polymers |
US7458953B2 (en) * | 2006-06-20 | 2008-12-02 | Gholam A. Peyman | Ocular drainage device |
US20090061515A1 (en) * | 2007-08-29 | 2009-03-05 | Michael Eric Benz | Methods of inhibiting or suppressing cellular proliferation |
MX2010005857A (es) * | 2007-11-28 | 2010-11-22 | Mersana Therapeutics Inc | Conjugados de analogos de fumagillina biodegradables biocompatibles. |
US8101706B2 (en) | 2008-01-11 | 2012-01-24 | Serina Therapeutics, Inc. | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same |
PA8853201A1 (es) * | 2008-12-10 | 2010-07-27 | Mersana Therapeutics Inc | Formulaciones farmaceuticas de conjugados de camtotecina-polimero biocompatibles biodegradables |
SI2889043T1 (sl) | 2008-12-16 | 2019-08-30 | Genzyme Corporation | Sintetične vmesne spojine za pripravo konjugatov oligosaharid-protein |
WO2010138719A1 (fr) | 2009-05-28 | 2010-12-02 | Mersana Therapeutics, Inc. | Conjugués de médicament/polyal comprenant des liants à taux de libération variable |
JP2013528665A (ja) | 2010-03-26 | 2013-07-11 | メルサナ セラピューティックス, インコーポレイテッド | ポリヌクレオチドの送達のための修飾ポリマー、その製造方法、およびその使用方法 |
WO2012129070A2 (fr) | 2011-03-24 | 2012-09-27 | Unversity Of Florida Research Foundation, Inc. | Polymérisation par métathèse d'acétal |
EP3228325A1 (fr) | 2011-06-10 | 2017-10-11 | Mersana Therapeutics, Inc. | Conjugués protéine-polymère-médicament |
US20140017265A1 (en) * | 2012-07-05 | 2014-01-16 | Mersana Therapeutics, Inc. | Terminally Modified Polymers and Conjugates Thereof |
CA2892863C (fr) | 2012-12-10 | 2022-03-15 | Mersana Therapeutics, Inc. | Echafaudage polymere fonde sur des filaments helicoidaux apparies (phf) pour l'administration ciblee de medicaments |
US10226535B2 (en) | 2012-12-10 | 2019-03-12 | Mersana Therapeutics, Inc. | Auristatin compounds and conjugates thereof |
CN105377355A (zh) | 2013-03-14 | 2016-03-02 | 拇趾公司 | 治疗甲单元的感染、疾病或病症的方法 |
JP6427564B2 (ja) | 2013-10-11 | 2018-11-21 | アサナ・バイオサイエンシズ,リミテッド・ライアビリティ・カンパニー | タンパク質−ポリマー−薬物共役体 |
EP3054991B1 (fr) | 2013-10-11 | 2019-04-03 | Mersana Therapeutics, Inc. | Conjugués de médicament-protéine-polymère |
TWI695011B (zh) | 2014-06-18 | 2020-06-01 | 美商梅爾莎納醫療公司 | 抗her2表位之單株抗體及其使用之方法 |
CN104877127B (zh) | 2015-06-23 | 2017-11-10 | 厦门赛诺邦格生物科技股份有限公司 | 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质 |
US11324827B2 (en) | 2014-10-01 | 2022-05-10 | Xiamen Sinopeg Biotech Co., Ltd. | Multifunctionalized polyethylene glycol derivative and preparation method therefor |
ES2941897T3 (es) | 2014-11-12 | 2023-05-26 | Seagen Inc | Compuestos que interaccionan con glicanos y procedimientos de uso |
IL258768B2 (en) | 2015-11-12 | 2023-11-01 | Siamab Therapeutics Inc | Compounds interacting with glycans and methods of use |
EP4302782A3 (fr) | 2016-03-15 | 2024-03-27 | Mersana Therapeutics, Inc. | Conjugués anticorps-médicament ciblant napi2b et leurs procédés d'utilisation |
EP3541847A4 (fr) | 2016-11-17 | 2020-07-08 | Seattle Genetics, Inc. | Composés interagissant avec le glycane et méthodes d'utilisation |
WO2018160538A1 (fr) | 2017-02-28 | 2018-09-07 | Mersana Therapeutics, Inc. | Polythérapies de conjugués anticorps-médicament ciblant her2 |
KR20240044544A (ko) | 2017-03-03 | 2024-04-04 | 씨젠 인크. | 글리칸-상호작용 화합물 및 사용 방법 |
CN111315414A (zh) | 2017-06-22 | 2020-06-19 | 梅尔莎纳医疗公司 | 产生载药聚合物支架和蛋白-聚合物-药物缀合物的方法 |
WO2023012798A2 (fr) | 2021-08-02 | 2023-02-09 | Yeda Research And Development Co. Ltd. | Anticorps pour le traitement du cancer |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024073A (en) * | 1972-01-08 | 1977-05-17 | Toray Industries, Inc. | Hydrogel and production thereof |
US4303767A (en) * | 1976-12-02 | 1981-12-01 | Basf Wyandotte Corporation | Flame retardant antistatic additives and antistatic fibers |
US4304767A (en) * | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
EP0051707A1 (fr) * | 1980-11-12 | 1982-05-19 | Thomas Clemens Usher | Acides polycarboxyliques de dextrane, leurs complexes avec l'hydroxyde de fer trivalent; compositions pharmaceutiques les contenant et procédé pour leur fabrication |
JPS59124901A (ja) * | 1982-12-29 | 1984-07-19 | Dai Ichi Seiyaku Co Ltd | 多糖誘導体 |
US4549010A (en) * | 1984-06-27 | 1985-10-22 | Merck & Co., Inc. | Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal |
US4863964A (en) * | 1985-07-02 | 1989-09-05 | Biomedical Frontiers, Inc. | Method for the stabilization of deferoxamine to chelate free ions in physiological fluid |
US4713441A (en) * | 1986-08-01 | 1987-12-15 | Sandoz Pharmaceuticals Corp. | Polyacetal hydrogels formed from divinyl ethers and polyols |
US4793986A (en) * | 1987-02-25 | 1988-12-27 | Johnson Matthey, Inc. | Macromolecular platinum antitumor compounds |
JPH01190636A (ja) * | 1988-01-22 | 1989-07-31 | Green Cross Corp:The | 制癌作用物質複合体 |
US4975519A (en) * | 1989-05-12 | 1990-12-04 | Hoechst Celanese Corporation | Novel polyacetal terpolymers of trioxane and alpha, alpha- and alpha, beta-isomers of glycerol formal and functional derivatives thereof |
US5202434A (en) * | 1991-04-05 | 1993-04-13 | Merck & Co., Inc. | 8a-aza-8a-homoerythromycin lactams |
EP0581752B1 (fr) * | 1992-07-15 | 1998-12-09 | The Procter & Gamble Company | Compositions pour éviter le transfert de colorant contenant des adjuvants |
US5393737A (en) * | 1992-08-20 | 1995-02-28 | Health Research, Inc. | Cytotoxic drug conjugates for treatment of neoplastic diseases |
US5359071A (en) * | 1993-03-12 | 1994-10-25 | Merck & Co., Inc. | 15-substituted 4-azasteroids |
-
1995
- 1995-04-14 US US08/421,766 patent/US5811510A/en not_active Expired - Lifetime
-
1996
- 1996-04-01 CA CA002215997A patent/CA2215997C/fr not_active Expired - Lifetime
- 1996-04-01 DK DK96912522T patent/DK0820473T4/da active
- 1996-04-01 WO PCT/US1996/004476 patent/WO1996032419A1/fr active IP Right Grant
- 1996-04-01 EP EP96912522A patent/EP0820473B2/fr not_active Expired - Lifetime
- 1996-04-01 JP JP53104096A patent/JP4187265B2/ja not_active Expired - Lifetime
- 1996-04-01 AT AT96912522T patent/ATE202573T1/de active
- 1996-04-01 AU AU55312/96A patent/AU5531296A/en not_active Abandoned
- 1996-04-01 DE DE69613569T patent/DE69613569T3/de not_active Expired - Lifetime
-
1997
- 1997-06-09 US US08/871,528 patent/US5863990A/en not_active Expired - Lifetime
-
1998
- 1998-12-07 US US09/207,102 patent/US5958398A/en not_active Expired - Lifetime
-
2001
- 2001-09-24 GR GR20010401553T patent/GR3036696T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0820473B1 (fr) | 2001-06-27 |
ATE202573T1 (de) | 2001-07-15 |
AU5531296A (en) | 1996-10-30 |
US5811510A (en) | 1998-09-22 |
CA2215997A1 (fr) | 1996-10-17 |
EP0820473A1 (fr) | 1998-01-28 |
DE69613569D1 (de) | 2001-08-02 |
DK0820473T3 (da) | 2001-10-22 |
CA2215997C (fr) | 2009-03-24 |
US5958398A (en) | 1999-09-28 |
DE69613569T2 (de) | 2002-05-16 |
EP0820473B2 (fr) | 2008-01-30 |
GR3036696T3 (en) | 2001-12-31 |
JP4187265B2 (ja) | 2008-11-26 |
JPH11503481A (ja) | 1999-03-26 |
WO1996032419A1 (fr) | 1996-10-17 |
DE69613569T3 (de) | 2008-07-24 |
US5863990A (en) | 1999-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0820473T3 (da) | Biologisk nedbrydelige polyacetalpolymerer og dannelse og anvendelse | |
DE69508938T2 (de) | Transdermales arzneistoff-abgabesystem | |
WO1996032419B1 (fr) | Polymeres de polyacetals biodegradables, formation et utilisation | |
DE69839251D1 (de) | Alpha interferon-polymer konjugate mit erhöhter biologischer wirksamkeit sowie verfahren zu deren herstellung | |
CA2355293A1 (fr) | Solutions de sel d'hydroxybutyrate stables et saines au plan microbiologique, pour le traitement de la narcolepsie | |
DE69634009D1 (de) | Implantierbare vorrichtung zur kontrollierten abgabe von arzneimitteln unmittelbar an einen inneren teil des körpers | |
KR900700089A (ko) | 전신성 피부 투과적 투여를 위한 약학적 조성물 | |
ES2184800T3 (es) | Uso de agentes anti-vegf en el tratamiento de la endometriosis. | |
TR199701490A2 (xx) | 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�. | |
ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
Hamilton | Announced Entrances in Greek Tragedy | |
EE9900428A (et) | Köhavastased ravimkoostised | |
WO2001024783A3 (fr) | Utilisation de (+)-tramadol, de o-demethyltramadol ou de (+)-o-demethyltramadol, de o-desmethyle-n-mono-desmethyl-tramadol ou de (+)o-desmethyl-n-mono-desmethyl-tramadol pour traiter l'incontinence urinaire | |
SE9202208D0 (sv) | Vaevnadsfoerstaerkning | |
ATE422893T1 (de) | Mannose-rezeptor tragende zellinie und antigen zusammensetzung | |
CO5280202A1 (es) | Metodos de tratamiento y metodos de rastreo de farmacos | |
BR0115882A (pt) | Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária | |
HUP9902415A2 (hu) | Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására | |
PT1058544E (pt) | Inibicao da actividade do tnf | |
FR2734724B1 (fr) | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme | |
WO2001042205A3 (fr) | Traitement de maladies enteriques inflammatoires avec des composes de la vitamine d | |
TR200000890T2 (tr) | Topik ilacın üretilmesi için -amino levülozik asidin kullanılması | |
CA2118997A1 (fr) | Derives du benzimidazole, leur preparation et leur utilisation | |
SE9700617D0 (sv) | New composition | |
UA31955A (uk) | Спосіб лікування гіпогалактії у породіль групи ризику |